---
document_datetime: 2023-09-21 17:31:26
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vedrop-epar-all-authorised-presentations_en.pdf
document_name: vedrop-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8485657
conversion_datetime: 2025-12-31 01:46:05.360779
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Procedure number   | Invented name   | Strength   | Pharmaceutical Form   | Route of administration   | Packaging           | Content          | Package size                 |
|-----------------------|-----------------|------------|-----------------------|---------------------------|---------------------|------------------|------------------------------|
| EU/1/09/533//001      | Vedrop          | 50 mg/ml   | Oral solution         | Oral use                  | bottle (glass/HDPE) | 10 ml (50 mg/ml) | 1 bottle + 1 ml oral syringe |
| EU/1/09/533//002      | Vedrop          | 50 mg/ml   | Oral solution         | Oral use                  | bottle (glass/HDPE) | 20 ml (50 mg/ml) | 1 bottle + 1 ml oral syringe |
| EU/1/09/533//003      | Vedrop          | 50 mg/ml   | Oral solution         | Oral use                  | bottle (glass/HDPE) | 60 ml (50 mg/ml) | 1 bottle + 2 ml oral syringe |